Challenge
To
safely
focus
the highest dose to the
intraprostatic
lesion, because most recurrences originate at the initial
tumour site.
•
Condition 1:
no compromise in CTV dose as prostate cancer
mostly is multifocal
•
Condition 2:
no increase in rectal complication probability